Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2011-03-01
2011-03-01
Gabel, Gailene R (Department: 1641)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
C435S007100, C435S007250, C530S322000, C530S402000, C530S403000, C530S387300, C436S506000, C436S507000, C436S513000, C436S518000, C436S523000, C436S524000, C436S527000, C436S533000, C436S534000, C436S538000, C436S010000, C436S175000, C436S177000
Reexamination Certificate
active
07897328
ABSTRACT:
The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection and blood typing.
REFERENCES:
patent: 4603209 (1986-07-01), Tsien et al.
patent: 4654267 (1987-03-01), Ugelstad et al.
patent: 4714763 (1987-12-01), Theodoropulos
patent: 4774339 (1988-09-01), Haugland et al.
patent: 4810636 (1989-03-01), Corey
patent: 4812409 (1989-03-01), Babb et al.
patent: 4849362 (1989-07-01), DeMarinis et al.
patent: 4981977 (1991-01-01), Southwick et al.
patent: 5132432 (1992-07-01), Haugland et al.
patent: 5187288 (1993-02-01), Kang et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5242805 (1993-09-01), Naleway et al.
patent: 5248782 (1993-09-01), Haugland et al.
patent: 5268486 (1993-12-01), Waggoner et al.
patent: 5274113 (1993-12-01), Kang et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5433896 (1995-07-01), Kang et al.
patent: 5451343 (1995-09-01), Neckers et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5459276 (1995-10-01), Kuhn et al.
patent: 5486616 (1996-01-01), Waggoner et al.
patent: 5501980 (1996-03-01), Katerinopoulos et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5516946 (1996-05-01), Jackson et al.
patent: 5569587 (1996-10-01), Waggoner
patent: 5569766 (1996-10-01), Waggoner et al.
patent: 5627027 (1997-05-01), Waggoner
patent: 5696157 (1997-12-01), Wang et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5776711 (1998-07-01), Vyas et al.
patent: 5808044 (1998-09-01), Brush et al.
patent: 5830912 (1998-11-01), Gee et al.
patent: 5877310 (1999-03-01), Reddington et al.
patent: 6002003 (1999-12-01), Shen et al.
patent: 6004536 (1999-12-01), Leung et al.
patent: 6008373 (1999-12-01), Waggoner et al.
patent: 6043025 (2000-03-01), Minden et al.
patent: 6127134 (2000-10-01), Minden et al.
patent: 6130094 (2000-10-01), Waggoner et al.
patent: 6130101 (2000-10-01), Mao et al.
patent: 6133445 (2000-10-01), Waggoner et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6162931 (2000-12-01), Gee et al.
patent: 6229055 (2001-05-01), Klaubert et al.
patent: 6339392 (2002-01-01), Ashihara
patent: 6514714 (2003-02-01), Lee et al.
patent: 6664047 (2003-12-01), Haugland et al.
patent: 6686457 (2004-02-01), Nilsson
patent: 6716979 (2004-04-01), Diwu et al.
patent: 6974873 (2005-12-01), Leung et al.
patent: 6977305 (2005-12-01), Leung et al.
patent: 2003/0073822 (2003-04-01), Lofling et al.
patent: 0 274 847 (1988-07-01), None
patent: 1 065 250 (2001-01-01), None
patent: 97/40104 (1997-10-01), None
patent: WO 99/51702 (1999-10-01), None
patent: WO 01/21624 (2001-03-01), None
patent: WO 02/26891 (2002-04-01), None
Rydberg et al., In vitro assessment of a new ABO immunoabsorbent with synthetic carbohydrates attached to sephatose (Transpl. Int. 17: 666-672 (2005)- published online Nov. 17, 2004).
Holgersson et al., Characteristics of protein-carbohydrate interactions as a basis of developing novel carbohydrate-based antirejection therapies, Immunology and Cell Biology 83: 694-708 (2005).
Beverloo et al., “Immunochemical Detection of Proteins and Nucleic Acids on Filters Using Small Luminescent Inorganic Crystals as Markers,”Anal. Biochem., 203(2):326-334 (1992).
Clausen et al., “ABH and Related Histo-Blood Group Antigens; Immunochemical Differences in Carriers Isotypes and Their Distribution”,Vox Sang, 56:1-20 (1989).
Davies et al., “Antibody-Antigen Complexes”,Annu. Rev. Biochem., 59:439-473 (1990).
Furukawa et al., “A1and A2Erythrocytes Can be Distinguished by Reagents That Do Not Detect Structural Differences Between the Two Cell Types”,J. Immunol., 135(6):4090-4094 (1985).
GenBank Accession No. Q10984 (Jul. 2007).
GenBank Accession No. Q10983 (Jul. 2007).
GenBank Accession No. Q10981 (Jul. 2007).
GenBank Accession No. AF455028 (Sep. 2003).
GenBank Accession No. NM—000148 (Sep. 2007).
GenBank Accession No. P19526 (Aug. 2007).
GenBank Accession No. BAA11638 Feb. 2006).
GenBank Accession No. D82933 (Feb. 2006).
GenBank Accession No. NP—663625 (Nov. 2006).
GenBank Accession No. NM—145650 (Nov. 2006).
GenBank Accession No. CAD10625 (Apr. 2005).
GenBank Accession No. AJ417832 (Apr. 2005).
GenBank Accession No. XP—140694 (Oct. 2002).
GenBank Accession No. XM—140694 (Oct. 2002).
GenBank Accession No. XP—006867 (Aug. 2002).
GenBank Accession No. XM—006867 Aug. 2002).
GenBank Accession No. NP—033177 (Jul. 2007).
GenBank Accession No. NM—009151 (Jul. 2007).
Liu et al., “Anti-Pig Antibody Absorption Efficacy of α-Gal Carrying Recombinant P-Selectin Glycoprotein Ligand-1/Immunoglobulin Chimeras Increases With Core 2 β1,6-N-Acetylglucosaminyltransferase Expression”,Glycobiology, 15(6):571-583 (2005).
Liu et al., “Removal of Xenoreactive Human Anti-Pig Antibodies by Absorption on Recombinant Mucin-Containing Glycoproteins Carrying the GALα1,3GAL Epitope”,Transplantation, 63(11):1673-1682 (1997).
Liu et al., “Multivalent Galα1,3Gal-Substitution Makes Recombinant Mucin-Immunoglobulins Efficient Absorbers of Anti-Pig Antibodies”,Xenotransplantation, 10(2):149-163 (2003).
Löfling et al., “Absorption of Anti-Blood Group A Antibodies on P-Selectin Glycoprotein Ligand-1/Immunoglobulin Chimeras Carrying Blood Group A Determinants: α1,2 Fucosyltransferases in Different Host Cells”,Glycobiology, 12(3):173-182 (2002).
Malmqvist, M., “Biospecific Interaction Analysis Using Biosensor Technology”,Nature, 361(6408):186-187 (1993).
Mammen et al., “Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors”,Angew. Chem. Int. Ed., 37:2754-2794 (1998).
Oriol et al., “A New Genetic Model Proposing That theSeGene Is a Structural Gene Closely Linked to theHGene”,Am. J. Hum. Genet., 33:421-431 (1981).
Rydberg et al., “In Vitro Assessment of a New ABO Immuno-Sorbent with Synthetic Carbohydrates Attached to Sepharose”,Tranpl. Int., 17(11):666-672 (2005).
Rydberg, L., “ABO-Incompatibility in Solid Organ Transplantation”,Transfusion Med., 11(4):325-342 (2001).
Smith et al., “Single-Step Purification of Polypeptides Expressed inEscherichia colias Fusions with Glutathione S-Transferase”,Gene, 67(1):31-40 (1988).
Sonnenday et al., “Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy”,Am. J. Transplant., 4:1315-1322 (2004).
Stegall et al., “ABO-Incompatible Kidney Transplantation”,Transplanation, 78(5):635-640 (2004).
Tanabe et al., “Removal of Anti-A/B Antibodies for Successful Kidney Transplantation Between ABO Blood Type Incompatible Couples”Transfusion Sci., 17(3):455-462 (1996).
Tydén et al., “ABO Incompatible Kidney Transplantations Without Splenectomy, Using Antigen-Specific Immunoadsorption and Rituximab”Am. J. Transplant., 5(1):145-148 (2005).
Tydén et al., “Successful ABO-Incompatible Kidney Transplantations Without Splenectomy Using Antigen-Speicific Immunoadsorption and Rituximab”,Transplanation, 76(4):730-743 (2003).
Warren et al., “Successful Renal Transplantation across Simultaneous ABO Incompatible and Positive Crossmatch Barriers”,Am. J. Transplant., 4(4):561-568 (2004).
Welsh et al., “Transplantation of Blood Group A2Kidneys Into O or B Recipients: The Effect of Pretransplant Anti-A Titers on Graft Survival”,Transplant. Proceedings., 19(6):4565-4567 (1987).
Yamamoto, F., “Review: ABO Blood Group System—ABH Oligosaccharide Antigens, Anti-A and Anti-B, A and B Glycosyltransferases, andABOGenes”,Immunohematol., 20(1):3-22 (2004).
Holgersson et al., “Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies”,Immunol. Cell Biol., 83 6):694-708 (2005).
Löfling et al., “Absorption of anti-bloo
Grufman Per
Holgersson Jan
Lindberg Linda
Liu Jining
AbSorber AB
Elrifi Ivor R.
Gabel Gailene R
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Blood group antigens of different types for diagnostic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood group antigens of different types for diagnostic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood group antigens of different types for diagnostic and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683354